Avinger,Inc. (NASDAQ:AVGR) Files An 8-K Submission of Matters to a Vote of Security Holders

Avinger,Inc. (NASDAQ:AVGR) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.

Story continues below

On June8, 2018, Avinger,Inc. (the “Company”) held its 2018 Annual Meeting of Stockholders (the “Annual Meeting”). Present at the Annual Meeting in person or by proxy were holders of 3,565,323 shares of the Company’s common stock, representing 73.65% of the voting power of the shares of the Company’s common stock as of April9, 2018, the record date for the Annual Meeting, and constituting a quorum for the transaction of business. The matters before the annual meeting are described in more detail in the Company’s definitive proxy statement filed with the United States Securities and Exchange Commission on April27, 2018.

Proposal 1 — Election of Directors. The following nominee was elected as a ClassIII director to serve until the 2021 Annual Meeting of Stockholders and until his successor is duly elected and qualified:

Nominee

VotesFor

VotesWithheld

BrokerNon- votes

James G. Cullen

635,686

102,224

2,827,413

Proposal 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm. The appointment of Moss Adams LLP as the Company’s independent registered public accounting firm for its fiscal year ending December31, 2018 was ratified.

VotesFor

VotesAgainst

Abstentions

BrokerNon-votes

3,399,007

136,614

29,702

Proposal 3 — Approval of the Amendment of the Avinger,Inc. 2015 Equity Incentive Plan. The amendment of the Company’s 2015 Equity Incentive Plan was approved.

VotesFor

VotesAgainst

Abstentions

BrokerNon-votes

446,155

286,902

4,853

2,827,413

Proposal 4 — Approval of the Potential Issuance of Greater than 19.99% of Outstanding Common Stock upon the Conversion of SeriesA Preferred Stock. The potential issuance of greater than 19.99% of outstanding common stock upon the conversion of SeriesA preferred stock was approved.

VotesFor

VotesAgainst

Abstentions

BrokerNon-votes

490,321

204,855

42,734

2,827,413


About Avinger,Inc. (NASDAQ:AVGR)

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company’s products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

An ad to help with our costs